Lung Transplant Outcomes in Donors Managed with Airway Pressure Release Ventilation

  • Biswas Roy S
  • Haworth C
  • Olson M
  • et al.
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Purpose: Airway pressure release ventilation (APRV), a pressure-control type of mechanical ventilation, is used for lung recruitment in cadaveric donor lungs. APRV elevates PaO2 in donor lungs, but clinical outcomes in transplant recipients with APRV-managed donor lungs are unreported. Methods: We retrospectively reviewed patients who underwent lung transplantation (LTx) from 2012 to 2013. Patients were divided into 2 groups based on mode of ventilation used during donor management and organ extraction (Group A, non-APRV; Group B, APRV). Probability of survival at 90 days, 1 year, and 3 years was analyzed using Kaplan-Meier estimates. Multivariate Cox regression was used to calculate adjusted risk of survival. Results: Of the 126 LTx (with cadaveric donors) performed during the study period, 9 recipients were excluded because their donors' lungs were maintained on portable ventilation perfusion systems. Of the remaining 117 patients, 81 (69%) were in Group A; 36 (31%) were in Group B. Baseline characteristics (e.g., preoperative recipient characteristics [age, sex, lung allocation score, type of end-stage lung disease]) were comparable between groups. Donors for Group B recipients were older (p= 0.03) and had higher body mass index (p< 0.001), higher incidence of chest trauma (p= 0.008), longer duration of ventilation after brain death (p< 0.001), and higher preexplant PaO2/FiO2 ratios (p< 0.001). After LTx, mechanical ventilation duration, postoperative length of stay, and median survival were similar in both groups. A Cox regression model showed comparable risk of death in both groups over 3 years (HR= 0.83, 95% CI 0.43, 1.62). Conclusion: APRV is an effective pre-LTx donor lung management strategy. Despite older donors with longer ventilation times, pre-explant PaO2/FiO2 ratios were still better in donors with APRV than without. Short-and long-term survival outcomes were comparable in LTx recipients at our center regardless of ventilation mode. Larger multi-center studies would likely validate these data (Figure presented).

Cite

CITATION STYLE

APA

Biswas Roy, S., Haworth, C., Olson, M., Kang, P., Varsch, K. E., Panchabhai, T. S., … Walia, R. (2017). Lung Transplant Outcomes in Donors Managed with Airway Pressure Release Ventilation. The Journal of Heart and Lung Transplantation, 36(4), S318–S319. https://doi.org/10.1016/j.healun.2017.01.1527

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free